Search Results - "Eberstål, Sofia"
-
1
Identification of two distinct mesenchymal stromal cell populations in human malignant glioma
Published in Journal of neuro-oncology (01-01-2017)“…Gene profiling has revealed that malignant gliomas can be divided into four distinct molecular subtypes, where tumors with a mesenchymal gene expression are…”
Get full text
Journal Article -
2
Low‐dose irradiated mesenchymal stromal cells break tumor defensive properties in vivo
Published in International journal of cancer (01-11-2018)“…Solid tumors, including gliomas, still represent a challenge to clinicians and first line treatments often fail, calling for new paradigms in cancer therapy…”
Get full text
Journal Article -
3
Intratumoral COX‐2 inhibition enhances GM‐CSF immunotherapy against established mouse GL261 brain tumors
Published in International journal of cancer (01-06-2014)“…Immunotherapy has shown effectiveness against experimental malignant brain tumors, but the clinical results have been less convincing most likely due to…”
Get full text
Journal Article -
4
Intratumoral temozolomide synergizes with immunotherapy in a T cell-dependent fashion
Published in Cancer Immunology, Immunotherapy (01-09-2013)“…Despite temozolomide (TMZ) treatment, the prognosis for patients with glioblastoma multiforme is still dismal. As dose escalation of TMZ is limited by systemic…”
Get full text
Journal Article -
5
A standardized and reproducible protocol for serum-free monolayer culturing of primary paediatric brain tumours to be utilized for therapeutic assays
Published in Scientific reports (17-07-2015)“…In vitro cultured brain tumour cells are indispensable tools for drug screening and therapeutic development. Serum-free culture conditions tentatively preserve…”
Get full text
Journal Article -
6
IFNγ in combination with IL-7 enhances immunotherapy in two rat glioma models
Published in Journal of neuroimmunology (15-05-2013)“…Abstract Peripheral immunization, using a combination of interferon-gamma (IFNγ)- and interleukin-7 (IL-7)-producing tumor cells, eradicated 75% of…”
Get full text
Journal Article -
7
Immunizations with unmodified tumor cells and simultaneous COX-2 inhibition eradicate malignant rat brain tumors and induce a long-lasting CD8+ T cell memory
Published in Journal of neuroimmunology (15-09-2014)“…Abstract Malignant brain tumors induce pronounced immunosuppression, which diminishes immune responses generated by immunotherapy. Here we report that…”
Get full text
Journal Article -
8
Inhibition of cyclooxygenase-2 enhances immunotherapy against experimental brain tumors
Published in Cancer Immunology, Immunotherapy (01-08-2012)“…Glioblastoma multiforme is the most common and aggressive malignant brain tumor in humans, and the prognosis is very poor despite conventional therapy…”
Get full text
Journal Article -
9
L ow‐dose irradiated mesenchymal stromal cells break tumor defensive properties in vivo
Published in International journal of cancer (01-11-2018)“…Solid tumors, including gliomas, still represent a challenge to clinicians and first line treatments often fail, calling for new paradigms in cancer therapy…”
Get full text
Journal Article -
10
Cure of established GL261 mouse gliomas after combined immunotherapy with GM‐CSF and IFNγ is mediated by both CD8+ and CD4+ T‐cells
Published in International journal of cancer (01-02-2009)“…We were the first to demonstrate that combined immunotherapy with GM‐CSF producing GL261 cells and recombinant IFNγ of preestablished GL261 gliomas could cure…”
Get full text
Journal Article -
11
Intratumorally implanted mesenchymal stromal cells potentiate peripheral immunotherapy against malignant rat gliomas
Published in Journal of neuroimmunology (2014)“…Abstract Bone marrow-derived mesenchymal stromal cells (MSCs) target glioma extensions and micro-satellites efficiently when implanted intratumorally. Here, we…”
Get full text
Journal Article -
12
Abstract 2409: Enhanced cell-based immunotherapy by IFNγ, IL-7 or COX-2 inhibition in a rat glioma model
Published in Cancer research (Chicago, Ill.) (15-04-2010)“…Abstract Introduction: Glioblastoma multiforme (GBM) is the most common brain tumor in adults and the median survival time after diagnosis is less than a year…”
Get full text
Journal Article -
13
Abstract LB-321: Changing the route of immunization determines outcome in immunotherapy of experimental brain tumors: Translation in development
Published in Cancer research (Chicago, Ill.) (15-04-2010)“…Abstract Introduction: Based on our previous experimental result we have performed a clinical trial at the Lund University Hospital, with immunotherapy using…”
Get full text
Journal Article -
14
Cure of established GL261 mouse gliomas after combined immunotherapy with GM-CSF and IFNgamma is mediated by both CD8+ and CD4+ T-cells
Published in International journal of cancer (01-02-2009)“…We were the first to demonstrate that combined immunotherapy with GM-CSF producing GL261 cells and recombinant IFNgamma of preestablished GL261 gliomas could…”
Get full text
Journal Article -
15